Littleton, MA, United States of America

Peter Jamison Rose

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 154(Granted Patents)


Location History:

  • New Rochelle, NY (US) (1991)
  • Littleton, MA (US) (2014 - 2024)

Company Filing History:


Years Active: 1991-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of Peter Jamison Rose

Introduction

Peter Jamison Rose is a notable inventor based in Littleton, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, he has made strides in developing innovative treatments for kidney diseases.

Latest Patents

Among his latest patents are "Inhibitors of APOL1 and methods of using same." This disclosure provides at least one entity chosen from compounds of formula (I), solid state forms of the same, compositions comprising the same, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD). Another patent under the same title further details a compound of Formula (I), including deuterated derivatives, pharmaceutically acceptable salts, and solvates thereof, solid state forms of those compounds, compositions comprising those compounds and solid forms, and methods of using the same, including use in treating focal segmental glomerulosclerosis (FSGS) and/or non-diabetic kidney disease (NDKD).

Career Highlights

Throughout his career, Peter has worked with prominent companies, including Vertex Pharmaceuticals, Inc. His work has significantly impacted the development of new therapeutic approaches in the medical field.

Collaborations

Peter has collaborated with notable coworkers such as Gerald J. Tanoury and William Aloysius Nugent, contributing to various innovative projects and advancements in his field.

Conclusion

Peter Jamison Rose's work exemplifies the spirit of innovation in the pharmaceutical industry, particularly in addressing critical health issues related to kidney diseases. His patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…